ASHLEY COOK: Open Payments
NPI 1558788232 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,084 in 95 payments from 14 companies in 2025. Trend: 2023 $1,095 · 2024 $1,433 · 2025 $2,084
Food & beverage: $2,084
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 28 | $492 |
| GENZYME CORPORATION | 12 | $355 |
| Regeneron Healthcare Solutions, Inc. | 8 | $213 |
| Viatris Specialty LLC | 10 | $204 |
| Verona Pharma, Inc. | 7 | $164 |
| AstraZeneca Pharmaceuticals LP | 9 | $163 |
| Amgen Inc. | 6 | $119 |
| Grifols USA, LLC | 4 | $118 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $76 |
| Baxter Healthcare | 2 | $50 |
Products named: DUPIXENT, NUCALA, TRELEGY ELLIPTA, YUPELRI, Ohtuvayre, TEZSPIRE, Prolastin-C Liquid, FASENRA.
Industry payments across LA — which companies pay providers there.
